Works matching DE "RILPIVIRINE"

Results: 166

Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report.
Published in:
2020
By:
- Cattaneo, Dario;
- Formenti, Tiziana;
- Isabella, Bronzino;
- Filice, Carlo;
- Fusi, Marta;
- Gervasoni, Cristina
Publication type:
Letter
Safety, tolerability and pharmacokinetics of rilpivirine following administration of a long-acting formulation in healthy volunteers.
Published in:
HIV Medicine, 2015, v. 16, n. 8, p. 477, doi. 10.1111/hiv.12247
By:
- Verloes, R;
- Deleu, S;
- Niemeijer, N;
- Crauwels, H;
- Meyvisch, P;
- Williams, P
Publication type:
Article
Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study.
Published in:
HIV Medicine, 2015, v. 16, n. 2, p. 132, doi. 10.1111/hiv.12183
By:
- Gantner, P;
- Reinhart, S;
- Partisani, M;
- Baldeyrou, M;
- Batard, M‐L;
- Bernard‐Henry, C;
- Cheneau, C;
- Mautort, E;
- Priester, M;
- Fafi‐Kremer, S;
- Muret, P;
- Rey, D
Publication type:
Article
Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapy.
Published in:
HIV Medicine, 2014, v. 15, n. 10, p. 611, doi. 10.1111/hiv.12157
By:
- Rokx, C;
- Verbon, A;
- Rijnders, BJA
Publication type:
Article
Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/m L in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials.
Published in:
HIV Medicine, 2014, v. 15, n. 1, p. 57, doi. 10.1111/hiv.12071
By:
- Molina, J‐M;
- Clumeck, N;
- Orkin, C;
- Rimsky, LT;
- Vanveggel, S;
- Stevens, M
Publication type:
Article
Neurological and psychiatric tolerability of rilpivirine ( TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks Neurological and psychiatric tolerability of rilpivirine ( TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks
Published in:
HIV Medicine, 2013, v. 14, n. 7, p. 391, doi. 10.1111/hiv.12012
By:
- Mills, AM;
- Antinori, A;
- Clotet, B;
- Fourie, J;
- Herrera, G;
- Hicks, C;
- Madruga, JV;
- Vanveggel, S;
- Stevens, M;
- Boven, K
Publication type:
Article
Crystal structure of rilpivirine, C22H18N6.
Published in:
Powder Diffraction, 2015, v. 30, n. 2, p. 170, doi. 10.1017/S0885715615000196
By:
- Kaduk, James A.;
- Zhong, Kai;
- Blanton, Thomas N.
Publication type:
Article
Dolutegravir and rilpivirine for the maintenance treatment of virologically suppressed HIV-1 infection.
Published in:
Expert Review of Clinical Pharmacology, 2018, v. 11, n. 6, p. 561, doi. 10.1080/17512433.2018.1478726
By:
- Casado, Jose L.;
- Monsalvo, Marta;
- Rojo, Aurora M.;
- Fontecha, María;
- Rodriguez-Sagrado, Miguel A.
Publication type:
Article
Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings.
Published in:
AIDS Research & Therapy, 2017, v. 14, p. 1
By:
- Kiertiburanakul, Sasisopin;
- Boettiger, David;
- Oon Tek Ng;
- Nguyen Van Kinh;
- Merati, Tuti Parwati;
- Avihingsanon, Anchalee;
- Wing-Wai Wong;
- Man Po Lee;
- Chaiwarith, Romanee;
- Kamarulzaman, Adeeba;
- Kantipong, Pacharee;
- Fujie Zhang;
- Jun Yong Choi;
- Kumarasamy, Nagalingeswaran;
- Ditangco, Rossana;
- Do Duy Cuong;
- Oka, Shinichi;
- Lim Heng Sim, Benedict;
- Ratanasuwan, Winai;
- Penh Sun Ly
Publication type:
Article
Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients.
Published in:
2019
By:
- Soulie, Cathia;
- Santoro, Maria Mercedes;
- Charpentier, Charlotte;
- Storto, Alexandre;
- Paraskevis, Dimitrios;
- Carlo, Domenico Di;
- Gennari, William;
- Sterrantino, Gaetana;
- Zazzi, Maurizio;
- Perno, Carlo Federico;
- Calvez, Vincent;
- Descamps, Diane;
- Ceccherini-Silberstein, Francesca;
- Marcelin, Anne-Geneviève;
- Di Carlo, Domenico
Publication type:
journal article
Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen.
Published in:
2019
By:
- Dimeglio, Chloé;
- Raymond, Stéphanie;
- Nicot, Florence;
- Jeanne, Nicolas;
- Carcenac, Romain;
- Lefebvre, Caroline;
- Izopet, Jacques;
- French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group
Publication type:
journal article
Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study.
Published in:
2018
By:
- Ocampo, A;
- Domingo, P;
- Fernández, P;
- Diz, J;
- Barberá, J R;
- Sepúlveda, M A;
- Salgado, X;
- Rodriguez, M;
- Santos, J;
- Yzusqui, M;
- Fernández, P;
- Barberá, J R;
- Sepúlveda, M A;
- Mayorga, M I;
- Lorenzo, J F;
- Bahamonde, A;
- Bachiller, P;
- Martínez, E;
- Rozas, N;
- Torres, C
Publication type:
journal article
HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa.
Published in:
2017
By:
- Steegen, K.;
- Bronze, M.;
- Papathanasopoulos, M. A.;
- van Zyl, G.;
- Goedhals, D.;
- Variava, E.;
- MacLeod, W.;
- Sanne, I.;
- Stevens, W. S.;
- Carmona, S.
Publication type:
journal article
Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
Published in:
2016
By:
- Curran, Adrian;
- Rojas, Jhon;
- Cabello, Alfonso;
- Troya, Jesús;
- Imaz, Arkaitz;
- Domingo, Pere;
- Martinez, Esteban;
- Ryan, Pablo;
- Górgolas, Miguel;
- Podzamczer, Daniel;
- Knobel, Hernando;
- Gutiérrez, Félix;
- Ribera, Esteban
Publication type:
journal article
Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutations.
Published in:
2016
By:
- Tsunefusa Hayashida;
- Atsuko Hachiya;
- Hirotaka Ode;
- Takeshi Nishijima;
- Kiyoto Tsuchiya;
- Wataru Sugiura;
- Masafumi Takiguchi;
- Shinichi Oka;
- Hiroyuki Gatanaga;
- Hayashida, Tsunefusa;
- Hachiya, Atsuko;
- Ode, Hirotaka;
- Nishijima, Takeshi;
- Tsuchiya, Kiyoto;
- Sugiura, Wataru;
- Takiguchi, Masafumi;
- Oka, Shinichi;
- Gatanaga, Hiroyuki
Publication type:
journal article
Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans.
Published in:
2016
By:
- Hohmann, Nicolas;
- Reinhard, Raphael;
- Schnaidt, Sven;
- Witt, Lukas;
- Carls, Alexandra;
- Burhenne, Jürgen;
- Mikus, Gerd;
- Haefeli, Walter E.
Publication type:
journal article
Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2016, v. 71, n. 2, p. 367, doi. 10.1093/jac/dkv359
By:
- Neogi, Ujjwal;
- Häggblom, Amanda;
- Singh, Kamalendra;
- Rogers, Leonard C.;
- Rao, Shwetha D.;
- Amogne, Wondwossen;
- Schülter, Eugen;
- Zazzi, Maurizio;
- Arnold, Eddy;
- Sarafianos, Stefan G.;
- Sönnerborg, Anders
Publication type:
Article
HIV-1 CNS in vitro infectivity models based on clinical CSF samples.
Published in:
2016
By:
- Mora-Peris, Borja;
- Winston, Alan;
- Garvey, Lucy;
- Else, Laura J.;
- Shattock, Robin J.;
- Herrera, Carolina
Publication type:
journal article
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 2084, doi. 10.1093/jac/dkv049
By:
- Frange, Pierre;
- Assoumou, Lambert;
- Descamps, Diane;
- Chéret, Antoine;
- Goujard, Cécile;
- Tran, Laurent;
- Gousset, Marine;
- Avettand-Fenoël, Veronique;
- Bocket, Laurence;
- Fafi-Kremer, Samira;
- Guinard, Jerome;
- Morand-Joubert, Laurence;
- Nicot, Florence;
- Plantier, Jean-Christophe;
- Rogez, Sylvie;
- Wirden, Marc;
- Rouzioux, Christine;
- Meyer, Laurence;
- Chaix, Marie-Laure
Publication type:
Article
Steady-state pharmacokinetics of rilpivirine under different meal conditions in HIV-1-infected Ugandan adults.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 5, p. 1482, doi. 10.1093/jac/dku575
By:
- Lamorde, Mohammed;
- Walimbwa, Stephen;
- Byakika-Kibwika, Pauline;
- Katwere, Michael;
- Mukisa, Lillian;
- Sempa, Joseph B.;
- Else, Laura;
- Back, David J.;
- Khoo, Saye H.;
- Merry, Concepta
Publication type:
Article
Acute Hepatitis B Infection in a Patient With Confirmed Immunity on Long-Acting Cabotegravir/Rilpivirine.
Published in:
ACG Case Reports Journal, 2025, v. 12, n. 1, p. 1, doi. 10.14309/crj.0000000000001575
By:
- Boateng, William K. B.;
- Carlin, Neil;
- Spira, Etan;
- Szabela, Maria E.;
- Ezeh, Kosisochukwu J.
Publication type:
Article
Vismodegib treatment in a HIV positive patient on antiretroviral therapy.
Published in:
2018
By:
- Scalvenzi, Massimiliano;
- Villani, Alessia;
- Mazzella, Caterina;
- Cappello, Milena;
- De Fata Salvatores, Gaia;
- Costa, Claudia;
- Salvatores, Gaia De Fata
Publication type:
journal article
Importance of multidisciplinary collaboration for smooth kidney transplantation in HIV-infected patients with chronic kidney disease: a case report.
Published in:
Renal Replacement Therapy, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s41100-022-00435-2
By:
- Abe, Tetsuya;
- Ishii, Daisuke;
- Imura, Yuki;
- Noguchi, Ayano;
- Kitajima, Kazuki;
- Takeuchi, Yasuo;
- Wada, Tatsuhiko;
- Yoshida, Kazunari
Publication type:
Article
Analytical Method Development and Validation of Rilpivirine by RP-HPLC Method.
Published in:
International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 3, p. 368, doi. 10.31838/ijpr/2021.13.03.066
By:
- PATIL, JYOTI A.;
- SHAH, ROHIT R.
Publication type:
Article
Cabotegravir Plus Rilpivirine: First Approval.
Published in:
Drugs, 2020, v. 80, n. 9, p. 915, doi. 10.1007/s40265-020-01326-8
By:
- Markham, A.
Publication type:
Article
Dolutegravir/Rilpivirine: A Review in HIV-1 Infection.
Published in:
Drugs, 2018, v. 78, n. 16, p. 1741, doi. 10.1007/s40265-018-1005-4
By:
- Blair, Hannah A.
Publication type:
Article
Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Review of Its Use in HIV Infection.
Published in:
2014
By:
- Deeks, Emma
Publication type:
Journal Article
Effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, an antiretroviral single-tablet regimen for the treatment of HIV infection.
Published in:
Journal of Clinical Pharmacology, 2014, v. 54, n. 4, p. 378, doi. 10.1002/jcph.210
By:
- Custodio, Joseph M.;
- Yin, Xiang;
- Hepner, Mischa;
- Ling, Kah Hiing J.;
- Cheng, Andrew;
- Kearney, Brian P.;
- Ramanathan, Srinivasan
Publication type:
Article
The effect of rilpivirine on the pharmacokinetics of methadone in HIV-negative volunteers.
Published in:
Journal of Clinical Pharmacology, 2014, v. 54, n. 2, p. 133, doi. 10.1002/jcph.222
By:
- Crauwels, Herta M.;
- van Heeswijk, Rolf P.G.;
- Vandevoorde, Ann;
- Buelens, Annemie;
- Stevens, Marita;
- Hoetelmans, Richard M.W.
Publication type:
Article
Impact of Food and Different Meal Types on the Pharmacokinetics of Rilpivirine.
Published in:
Journal of Clinical Pharmacology, 2013, v. 53, n. 8, p. 834, doi. 10.1002/jcph.107
By:
- Crauwels, Herta M.;
- van Heeswijk, Rolf P.G.;
- Buelens, Annemie;
- Stevens, Marita;
- Boven, Katia;
- Hoetelmans, Richard M.W.
Publication type:
Article
Treatment modification in HIV-Infected individuals starting antiretroviral therapy between 2011 and 2014.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19768
By:
- Rappold, Michaela;
- Rieger, Armin;
- Steuer, Andrea;
- Geit, Maria;
- Sarcletti, Mario;
- Haas, Bernhard;
- Taylor, Ninon;
- Kanatschnig, Manfred;
- Leierer, Gisela;
- Ledergerber, Bruno;
- Zangerle, Robert
Publication type:
Article
The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19789
By:
- Rokx, Casper;
- Blonk, Maren;
- Verbon, Annelies;
- Burger, David;
- JA Rijnders, Bart
Publication type:
Article
Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic Study.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19631
By:
- Neukam, Karin;
- Espinosa, Nuria;
- Merino, Dolores;
- Rivero-Juárez, Antonio;
- Carrero, Ana;
- José Ríos, María;
- Ruiz-Morales, Josefa;
- Gómez-Berrocal, Ana;
- Téllez, Francisco;
- Díaz-Menéndez, Marta;
- Collado, Antonio;
- Pérez-Camacho, Inés;
- Delgado-Fernández, Marcial;
- Vera-Méndez, Francisco;
- Pineda, Juan A
Publication type:
Article
Safety of rilpivirine plus nucleoside reverse-transcriptase inhibitors in HIV-infected Taiwanese with a higher prevalence of hepatitis virus infection.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19580
By:
- Wu, Pei-Ying;
- Cheng, Chien-Yu;
- Luo, Yu-Zhen;
- Zhang, Jun-Yu;
- Yang, Shan-Ping;
- Cheng, Shu-Hsing;
- Hung, Chien-Ching
Publication type:
Article
Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in Italy.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19775
By:
- Cozzi-Lepri, Alessandro;
- Lo Caputo, Sergio;
- Maggiolo, Franco;
- Antinori, Andrea;
- Ammassari, Adriana;
- Marchetti, Giulia;
- Mastroianni, Claudio;
- Gori, Andrea;
- Di Perri, Giovanni;
- Angarano, Gioacchino;
- Carbone, Alessia;
- d'Arminio Monforte, Antonella
Publication type:
Article
Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19609
By:
- Llibre-Codina, Josep M;
- Andreu-Crespo, Angels;
- Cardona-Peitx, Gloria;
- Sala-Piñol, Ferran;
- Clotet-Sala, Bonaventura;
- Bonafont-Pujol, Xavier
Publication type:
Article
Switch to Stribild versus continuation of NVP or RPV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-NNRTI subgroup analysis.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19793
By:
- Stellbrink, Hans-Juergen;
- Antinori, Andrea;
- Pozniak, Anton;
- Flamm, Jason;
- Bredeek, Fritz;
- Patel, Kiran;
- Garner, Will;
- Piontkowsky, David
Publication type:
Article
Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera<sup>®</sup>). Efficacy and safety analysis. GeSida Study 8114.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19795
By:
- Pérez-Hernández, Isabel A;
- Palacios, Rosario;
- Mayorga, Marisa;
- González-Doménech, Carmen M;
- Castaño, Manuel;
- Rivero, Antonio;
- Arco, Alfonso;
- Lozano, Fernando;
- Santos, Jesús
Publication type:
Article
Efficacy and safety of rilpivirine-based regimens in treatment-experienced HIV-1 infected patients: a prospective cohort study.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19796
By:
- Gazaignes, Sandrine;
- Resche-Rigon, Matthieu;
- Yang, Chloe;
- Gatey, Caroline;
- Munier, Anne-Lise;
- Desseaux, Kristell;
- Rozenbaum, Willy;
- Molina, Jean-Michel
Publication type:
Article
Switching from an EFV-based STR to a RPV-based STR is effective, safe and improves HIV patients health status.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19798
By:
- Maggiolo, Franco;
- Di Matteo, Sergio;
- Bruno, Giacomo;
- Astuti, Noemi;
- Di Filippo, Elisa;
- Valenti, Daniela;
- Colombo, Giorgio
Publication type:
Article
Rilpivirine versus etravirine validity in NNRTI-based treatment failure in Thailand.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19740
By:
- Teeranaipong, Phairote;
- Sirivichayakul, Sunee;
- Mekprasan, Suwanna;
- Ruxrungtham, Kiat;
- Putcharoen, Opass
Publication type:
Article
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort.
Published in:
Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19812
By:
- Pinnetti, Carmela;
- Di Giambenedetto, Simona;
- Maggiolo, Franco;
- Lorenzini, Patrizia;
- Fabbiani, Massimiliano;
- Tommasi, Chiara;
- Latini, Alessandra;
- Ammassari, Adriana;
- Loiacono, Laura;
- Sterrantino, Gaetana;
- Bellagamba, Rita;
- Boumis, Evangelo;
- Antinori, Andrea;
- Zaccarelli, Mauro
Publication type:
Article
An unusual case of underlying rilpivirine resistance in an antiretroviral-naïve man with AIDS.
Published in:
2016
By:
- Skalweit, Marion J.
Publication type:
journal article
Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort.
Published in:
PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164753
By:
- Capetti, Amedeo F.;
- Sterrantino, Gaetana;
- Cossu, Maria Vittoria;
- Orofino, GianCarlo;
- Barbarini, Giorgio;
- De Socio, Giuseppe V.;
- Di Giambenedetto, Simona;
- Di Biagio, Antonio;
- Celesia, Benedetto M.;
- Argenteri, Barbara;
- Rizzardini, Giuliano
Publication type:
Article
Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
Published in:
PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164455
By:
- Troya, Jesús;
- Ryan, Pablo;
- Ribera, Esteban;
- Podzamczer, Daniel;
- Hontañón, Victor;
- Terrón, Jose Alberto;
- Boix, Vicente;
- Moreno, Santiago;
- Barrufet, Pilar;
- Castaño, Manuel;
- Carrero, Ana;
- Galindo, María José;
- Suárez-Lozano, Ignacio;
- Knobel, Hernando;
- Raffo, Miguel;
- Solís, Javier;
- Yllescas, María;
- Esteban, Herminia;
- González-García, Juan;
- Berenguer, Juan
Publication type:
Article
Lowered Rilpivirine Exposure During the Third Trimester of Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women.
Published in:
Clinical Infectious Diseases, 2017, v. 65, n. 8, p. 1335, doi. 10.1093/cid/cix534
By:
- Schalkwijk, Stein;
- Colbers, Angela;
- Konopnicki, Deborah;
- Gingelmaier, Andrea;
- Lambert, John;
- van der Ende, Marchina;
- Moltó, José;
- Burger, David
Publication type:
Article
Single-Tablet Emtricitabine-Rilpivirine- Tenofovir as HIV Postexposure Prophylaxis in Men Who Have Sex With Men.
Published in:
Clinical Infectious Diseases, 2015, v. 61, n. 8, p. 1336, doi. 10.1093/cid/civ511
By:
- Foster, Rosalind;
- McAllister, John;
- Read, Tim R.;
- Pierce, Anna B.;
- Richardson, Robyn;
- McNulty, Anna;
- Carr, Andrew
Publication type:
Article
Lipid Levels and Changes in Body Fat Distribution in Treatment-Naive, HIV-1–Infected Adults Treated With Rilpivirine or Efavirenz for 96 Weeks in the ECHO and THRIVE Trials.
Published in:
Clinical Infectious Diseases, 2014, v. 59, n. 3, p. 425
By:
- Tebas, Pablo;
- Sension, Michael;
- Arribas, José;
- Duiculescu, Dan;
- Florence, Eric;
- Hung, Chien-Ching;
- Wilkin, Timothy;
- Vanveggel, Simon;
- Stevens, Marita;
- Deckx, Henri
Publication type:
Article
Antiretroviral Chemoprophylaxis: State of Evidence and the Research Agenda.
Published in:
Clinical Infectious Diseases, 2014, v. 59, n. suppl_1, p. S47, doi. 10.1093/cid/ciu322
By:
- Mayer, Kenneth H.
Publication type:
Article
Naturally Selected Rilpivirine-Resistant HIV-1 Variants by Host Cellular Immunity.
Published in:
Clinical Infectious Diseases, 2013, v. 57, n. 7, p. 1051, doi. 10.1093/cid/cit430
By:
- Gatanaga, Hiroyuki;
- Murakoshi, Hayato;
- Hachiya, Atsuko;
- Hayashida, Tsunefusa;
- Chikata, Takayuki;
- Ode, Hirotaka;
- Tsuchiya, Kiyoto;
- Sugiura, Wataru;
- Takiguchi, Masafumi;
- Oka, Shinichi
Publication type:
Article